Thiamine deficiency aggravates experimental colitis in mice by promoting glycolytic reprogramming in macrophages
- 31 January 2025
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 182 (9) , 1897-1911
Abstract
Background and Purpose: Inflammatory bowel disease (IBD) is closely associated with immune dysfunction, where nutrient‐mediated metabolic flux dictates immune cell fate and function. Thiamine is a central water‐soluble vitamin involved in cellular energy metabolism, and its deficiency has been reported in IBD patients. However, whether thiamine deficiency is a cause or consequence of IBD pathogenesis remains unclear. The current study aimed to reveal the immunometabolic regulation of macrophages and underlying mechanism of thiamine deficiency in colitis development.Experimental Approach: Thiamine deficiency was induced in C57BL/6 mice and bone marrow‐derived macrophages (BMDMs), by administering a thiamine‐deficient diet/medium together with pyrithiamine hydrobromide. The frequency of macrophage phenotypes and their intracellular metabolism were detected using flow cytometry and non‐targeted metabolomics, respectively.Key Results: Thiamine deficiency aggravated ulcerative colitis in mice and promoted the infiltration of proinflammatory M1 macrophages in colonic lamina propria. Our mechanistic study revealed that thiamine deficiency impaired pyruvate dehydrogenase (PDH) activity, thereby reprogramming cellular glucose metabolism to enhance glycolysis and lactic acid accumulation in M1 macrophages. Using a well‐established PDH inhibitor (CPI‐613) and lactic acid dehydrogenase inhibitor (galloflavin), we further demonstrated that PDH inhibition mimics, while lactate dehydrogenase inhibition partially rescues, thiamine deficiency‐induced proinflammatory macrophage infiltration and experimental colitis in mice.Conclusion and Implications: Our study provides evidence linking thiamine deficiency with proinflammatory macrophage activation and colitis aggravation, suggesting that monitoring thiamine status and adjusting thiamine intake is necessary to protect against colitis.Keywords
Funding Information
- National Natural Science Foundation of China (31900644, 32300746)
- Fundamental Research Funds for the Central Universities (JUSRP121009)
- Natural Science Foundation of Jiangsu Province (BK20231047, BK20231042)
This publication has 56 references indexed in Scilit:
- Tissue-specific macrophage immunometabolismCurrent Opinion in Immunology, 2023
- Ulcerative ColitisGastroenterology Clinics of North America, 2020
- The role of thiamine dependent enzymes in obesity and obesity related chronic disease states: A systematic reviewClinical Nutrition ESPEN, 2018
- Vitamins and Minerals in Inflammatory Bowel DiseaseGastroenterology Clinics of North America, 2017
- Mode of Bioenergetic Metabolism during B Cell Differentiation in the Intestine Determines the Distinct Requirement for Vitamin B1Cell Reports, 2015
- Isolation, Culture, and Polarization of Murine Bone Marrow-Derived and Peritoneal Macrophages2015
- Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage FunctionImmunity, 2014
- Micronutrient deficiencies in inflammatory bowel disease: From A to zincInflammatory Bowel Diseases, 2012
- Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophagesFree Radical Biology and Medicine, 2010
- Structure, mechanism and catalytic duality of thiamine-dependent enzymesCellular and Molecular Life Sciences, 2007